release of MSW NMS NMS: SOME GOOD NEWS, BUT ... The RSU
NMS is convinced of the positivity of the latest news about the company (Redefining Agreement with Pfizer and the future of the Licensing nemorubicin to a Chinese company). Also claimed to have been among the first, for some years and sometimes ignored, questions were raised about the agreement with Pfizer halter and an interest in the question the media and the world Lombard and national politics and trade unions.
All this good news are not sufficient to consider unresolved issues NMS:
• the financial situation remains very precarious, partly because the new arrangements do not immediately translate into revenue for the Company •
for discovery is not yet been submitted to the new organizational model, beyond general indications appeared in the press
• For other companies it is unclear whether or not there will the entry of new members / partners and in what form
• the status of many utilities and infrastructure of the center is heavily influenced by the lack of investment for maintenance and / or updating them, resulting in difficulties in the work and contracts for third parties.
We therefore indispensable and urgent:
• that the "divorce" from Pfizer leads quickly to new agreements to bring in our pipeline and to clarify the orientation of the discovery
• it is decided once and for all the industrial structure Corporate and other operating units •
you reconvene the institutional table in the Lombardy Region, where the company presents its business plan in detail and not only in the guidelines
We hope that any new resources be allocated to the consolidation of the center's activities and to compensate for the sacrifices made in recent years by workers and employees of NMS (various PTO has not yet paid, contractual increases absorption, etc.). and not squandered for the payment of outstanding stability pact, signed in time , illusory, fat cows.
The RSU NMS, Thursday, June 17, 2010
